Exposure via body fluid
(UMLS:C3544190)
- UMLS ID:
- C3544190
- MeSH ID:
- N/A
Synonym(s)
1.
Exposure via body fluid
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Dasatinib | FAERS: 53 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 2 | Isotretinoin | FAERS: 45 | US FAERS | |
| 3 | entecavir | FAERS: 41 | US FAERS | |
| 4 | 4-hydroxybutyric acid | FAERS: 38 | US FAERS | |
| 5 | Finasteride | FAERS: 18 Canada Vigilance: 8 | Canada Vigilance US FAERS | |
| 6 | Aripiprazole | FAERS: 13 | US FAERS | |
| 7 | Dutasteride | FAERS: 7 | US FAERS | |
| 8 | Buprenorphine | FAERS: 6 | US FAERS | |
| 9 | Warfarin | FAERS: 6 | US FAERS | |
| 10 | Tenofovir | FAERS: 5 | US FAERS | |
| 11 | sofosbuvir-velpatasvir drug combination | FAERS: 5 | US FAERS | |
| 12 | PCI 32765 | FAERS: 4 | US FAERS | |
| 13 | Paroxetine | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 14 | Simvastatin | FAERS: 4 | US FAERS | |
| 15 | Abiraterone Acetate | FAERS: 3 | US FAERS | |
| 16 | Acitretin | FAERS: 3 | US FAERS | |
| 17 | Amoxicillin-Potassium Clavulanate Combination | FAERS: 3 | US FAERS | |
| 18 | Hydroxyurea | FAERS: 3 | US FAERS | |
| 19 | GS-7340 | FAERS: 2 | US FAERS | |
| 20 | Lamotrigine | FAERS: 2 | US FAERS | |
| 21 | Levetiracetam | FAERS: 2 | US FAERS | |
| 22 | Ribavirin | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 23 | Sorafenib | FAERS: 2 | US FAERS | |
| 24 | Temozolomide | FAERS: 2 | US FAERS | |
| 25 | ambrisentan | FAERS: 2 | US FAERS | |
| 26 | 2-(Tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydron;chloride | FAERS: 1 | US FAERS | |
| 27 | Cabozantinib S-malate | FAERS: 1 | US FAERS | |
| 28 | Citalopram | FAERS: 1 | US FAERS | |
| 29 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 30 | HhAntag691 | FAERS: 1 | US FAERS | |
| 31 | Jalyn | FAERS: 1 | US FAERS | |
| 32 | Lamivudine | FAERS: 1 | US FAERS | |
| 33 | Lenalidomide | FAERS: 1 | US FAERS | |
| 34 | Lisdexamfetamine Dimesylate | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 35 | MDV 3100 | FAERS: 1 | US FAERS | |
| 36 | Mercaptopurine | FAERS: 1 | US FAERS | |
| 37 | Metformin | FAERS: 1 | US FAERS | |
| 38 | Methotrexate | FAERS: 1 | US FAERS | |
| 39 | Naltrexone | FAERS: 1 | US FAERS | |
| 40 | NuvaRing | FAERS: 1 | US FAERS | |
| 41 | Olmesartan Medoxomil | FAERS: 1 | US FAERS | |
| 42 | Rivaroxaban | FAERS: 1 | US FAERS | |
| 43 | Ruxolitinib phosphate | FAERS: 1 | US FAERS | |
| 44 | Tamoxifen | FAERS: 1 | US FAERS | |
| 45 | Triumeq | FAERS: 1 | US FAERS | |
| 46 | Vardenafil Dihydrochloride | FAERS: 1 | US FAERS | |
| 47 | Warfarin | FAERS: 1 | US FAERS | |
| 48 | cabozantinib | FAERS: 1 | US FAERS | |
| 49 | edoxaban | FAERS: 1 | US FAERS | |
| 50 | elbasvir-grazoprevir drug combination | FAERS: 1 | US FAERS | |
| 51 | ledipasvir, sofosbuvir drug combination | FAERS: 1 | US FAERS | |
| 52 | osimertinib | FAERS: 1 | US FAERS | |
| 53 | pazopanib | FAERS: 1 | US FAERS | |
| 54 | rotigotine | FAERS: 1 | US FAERS | |
| 55 | Imatinib Mesylate | Canada Vigilance: 2 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.